Amanote Research
Register
Sign In
Responses of Cancer Cells With Wild-Type or Tyrosine Kinase Domain-Mutated Epidermal Growth Factor Receptor (EGFR) to EGFR-targeted Therapy Are Linked to Downregulation of Hypoxia-Inducible Factor-1α
Molecular Cancer
- United Kingdom
doi 10.1186/1476-4598-6-63
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Molecular Medicine
Date
January 1, 2007
Authors
Yang Lu
Ke Liang
Xinqun Li
Zhen Fan
Publisher
Springer Science and Business Media LLC
Related search
Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but Not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors
Cancer Research
Cancer Research
Oncology
Does the Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Differ According to the Type of EGFR Mutation in Non-Small Cell Lung Cancer?
Korean Journal of Internal Medicine
Internal Medicine
BRAF; Epidermal Growth Factor Receptor (EGFR)
Science-Business eXchange
The Tumor-Specific De2–7 Epidermal Growth Factor Receptor (EGFR) Promotes Cells Survival and Heterodimerizes With the Wild-Type EGFR
Oncogene
Cancer Research
Genetics
Molecular Biology
Phase 1 Trial of Dasatinib Combined With Afatinib for Epidermal Growth Factor Receptor- (EGFR-) Mutated Lung Cancer With Acquired Tyrosine Kinase Inhibitor (TKI) Resistance
British Journal of Cancer
Cancer Research
Oncology
Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer
HPB
Hepatology
Gastroenterology
Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma
Targeted Oncology
Cancer Research
Oncology
Pharmacology
AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?
Breast Cancer Research
Cancer Research
Oncology
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
JAMA - Journal of the American Medical Association
Medicine